The candidate vaccine’s next steps will be going through the FDA’s Biologics License Application process.
|Articles|October 2, 2020
Take Drug Topics' Annual Pharmacy Salary Survey
Every year, Drug Topics® asks pharmacists about their job experiences. Take our 2020 Annual Pharmacy Salary Survey here.
Advertisement
Every year, Drug Topics® asks pharmacists about their job experiences. We want to know about pharmacists' professional satisfaction—everything from salaries, raises, and bonuses to workload and stress levels.
Read more about
- Sixty-one percent of pharmacists said their stress levels increased at work in 2019 compared to 2018.
- The average salary reported in the 2010 survey was lower ($100,000-$130,000) compared to 2019, with nearly 50% of pharmacists in 2019 who said they make over the $130,000 mark.
- More than 18% of pharmacists said they were "extremely satisified" with their job compared to 9% of those who said they were "extremely dissatisfied".
- Common stress contributors cited in the 2019 survey included vaccination quotas, DIR fees, and new USP regulations.
Advertisement
Related to this article
The Milken Institute released survey results alongside new data regarding the need for pharmacists in extending effective GLP-1 care.
Through the ACCESS program, Mark Ey, RPh, notes that pharmacies can now start billing for a variety of services they’ve already been providing.
The medication significantly increased risk of pregnancy loss when compared with macrolide antibiotics, amoxicillin, and topical clindamycin for acne.
In part 3, Rebold explores improving the ART formulary protocol through introducing pharmacist-led transition-of-care services.
Our hosts explore why ketone monitoring matters, what pharmacists should know about Libre Duo, and how patient education can support proactive care management.
Mark Ey, RPh, details the patient-focused factors of the ACCESS to Pharmacy Care Program and the ways in which valued care translates to reimbursement.
A new option for adults who have experienced stroke will now be available to further reduce future risk.
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Adds NAION Eye Risk Warning to All GLP-1 Labels
2
The Pharmacy Model Creating New Billing Pathways, Improved Recognition
3
New Report Finds Pharmacies Key in Long-Term GLP-1 Success
4
Doxycycline Use Associated with Higher Risk of Pregnancy Loss
5